Form 4: Concentrix Executive Sells Shares Under Pre-Arranged Trading Plan
Insider Transaction Report
Cormac J. Twomey, EVP of Global Operations & Delivery at Concentrix Corp, sold 500 shares of common stock for $57.06 per share under a Rule 10b5-1 trading plan.
Summary
- Cormac J. Twomey, Executive Vice President of Global Operations & Delivery at Concentrix Corp (CNXC), reported a transaction involving the company's common stock.
- On May 30, 2025, Mr. Twomey disposed of 500 shares of Concentrix Common Stock.
- The shares were sold at a price of $57.06 per share.
- Following this transaction, Mr. Twomey directly beneficially owns 38,130 shares of Concentrix Common Stock.
- The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Twomey on January 28, 2025.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine insider sale conducted under a pre-arranged Rule 10b5-1 plan, which typically does not imply new material information or a change in management's outlook.
Positives
- The sale was conducted under a Rule 10b5-1 trading plan, adopted on January 28, 2025, indicating a pre-scheduled transaction rather than a reaction to immediate market conditions, which enhances transparency.
Negatives
- An executive, Cormac J. Twomey, sold 500 shares of common stock, resulting in a reduction of his direct beneficial ownership in the company.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Management Comments
- "This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2025."
Industry Context
This Form 4 filing is specific to an insider transaction at Concentrix Corp and does not provide broader industry trends or context.
Stakeholder Impact
- Shareholders: The transaction represents a minor reduction in direct insider ownership, though its execution under a Rule 10b5-1 plan suggests it was pre-planned and not based on new, undisclosed information.
Key Dates
| Date | Description |
|---|---|
| 01/28/2025 | Rule 10b5-1 trading plan adopted by the reporting person. |
| 05/30/2025 | Date of transaction (sale of common stock). |
| 06/02/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdKeywords
Concentrix, CNXC, Form 4, insider trading, stock sale, executive compensation, beneficial ownership, Rule 10b5-1, Cormac Twomey
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.